Thomas M. Gress, PhD
Chair, Gastroenterology; Director, University Hospitals
University of Marburg
Thomas Gress is chair of gastroenterology and director of the University Hospitals Department of Gastroenterology, Endocrinology, Metabolism, and Infectiology. Thomas Gress performed his medical training and obtained his medical doctorate at the University of Marburg in Germany. After completion of his medical training he conducted a postdoctoral fellowship in the genome analysis laboratory of Hans Lehrach at the Cancer Research UK Facilities in London (UK). There he was the first to apply gene array technology to generate an expression profile of human pancreatic cancer, which was the first array expression profile ever generated for a solid tumor.
After his postdoctoral years in London he moved to the Department of Gastroenterology of the University Hospital in Ulm, Germany, where he completed his clinical training for internal medicine, gastroenterology, infectiology, and gastrointestinal oncology. In Ulm, he was the head of a translational genome research group for pancreatic cancer and was among the first to apply high throughput genome technology for molecular diagnostics and candidate gene identification in pancreatic cancer. He was awarded the prestigous Heisenberg fellowship by the German Research Society (DFG) and was later appointed professor of gastroenterology at the University of Ulm. In 2006 he was appointed to his present positions at the University and University Hospital of Marburg. His clinical and scientific interest is focused on sporadic and hereditary pancreatic diseases and gastrointestinal oncology, in particular pancreatic cancer. His research group is conducting translational research projects in molecular diagnostics and therapeutics as well as mechanistic studies exploring the role of tumor-microenvironment interactions in cancerogenesis and in mediating resistance to therapy in pancreatic cancer. He has coordinated multiple national and international research networks on pancreatic cancer funded by the European Union, the German government and the German Cancer Aid (Deutsche Krebshilfe). He is associate editor of the journal GUT and member of the scientific committee of the United European Gastroenterology (UEG) and responsible for pancreatic diseases in both.